Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Graft-versus-host disease biomarkers: omics and personalized medicine.

International journal of hematology - 1 Sept 2013

Paczesny Sophie, Raiker Nisha, Brooks Sam, Mumaw Christy

Abstract excerpt

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective form of tumor immunotherapy available to date and the frequency of transplants continues to increase worldwide. However, while allo-HSCT usually induces a beneficial graft-versus leukemia effect, a major source of morbidity and mortality following allo-HSCT is graft-versus-host disease (GVHD). Currently available diagnostic and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Allografts
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft vs Host Disease

Share to HLA Antigens

Share to Precision Medicine

Share to Proteomics

Share to T-Lymphocytes, Regulatory

Source

Open in PubMed Open full text

Identifiers

PMID: 23959582
DOI: 10.1007/s12185-013-1406-9
PMCID: PMC4005044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Graft-versus-host disease biomarkers: omics and personalized medicine.PMID 23959582Read ↗

Graft-versus-host diseaseSemantic proximity Read ↗

Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and TreatmentSemantic proximity Read ↗

Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.Semantic proximity Read ↗

An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalSemantic proximity Read ↗

Advances in understanding the pathogenesis of graft‐versus‐host diseaseSemantic proximity Read ↗

A New Risk Score System for Early Warning Gastrointestinal Graft-Versus-Host Disease Based on the Immune Function of Mucosal-Associated Invariant T CellsSemantic proximity Read ↗

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDSemantic proximity Read ↗

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read ↗

Biomarkers in solid organ transplantation: establishing personalized transplantation medicineSemantic proximity Read ↗

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cellsSemantic proximity Read ↗

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantationSemantic proximity Read ↗

Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.